• Home
      »
    • Patients
        »
      • MeVac – Meilahti Vaccine Research Center

MeVac – Meilahti Vaccine Research Center

Vaccines provide a long-term, or evenlifelong, immunity to infectious diseases. Through research, we can develop new and better vaccines, and test the vaccines already in use and their suitability for protecting special populations, such as people with autoimmune diseases, pregnant women, children, or the elderly.
 
Participate in vaccine research
 
MeVac –about us
 
Mevac is a vaccine research center of HUS and the University of Helsinki. MeVac conducts both commissioned studies sponsored by pharmaceutical companies and academic, investigator-initiated studies. The center is headed by Anu Kantele, Professor of Infectious Diseases.
 
MeVac is centrally located in Biomedicum in the Meilahti Hospital area. The practical work is entrusted to a professional staff and the facilities are designed for clinical drug trials.
 
MeVac abides by Finnish and EU legislation governing medical research and clinical trial authorisations as well as following good clinical practice. The trials are registered in international research databases.
 
Vasemmalle
Oikealle
 

 Contact information

 
MeVac – Meilahti Vaccine Research Center
www.hus.fi/mevac
vaccine(at)hus.fi
 
Visiting address:
Biomedicum Helsinki 1 Haartmaninkatu 8
00290 Helsinki
 
Director of MeVac, Professor of Infectious Diseases 
Anu Kantele
+358 50 427 0203
 
MeVac Physician-in-charge, Adjunct Professor, Specialist in Otorhinolaryngology
Karin Blomgren
+358 50 427 1579
 
MeVac Research
Nurse-In-Charge
Rauni Pakarinen
+358 50 311 6365
 
Emails:
forename.surename(at)hus.fi
   
 
HUS_ENGL_RGB.png
 
 
HY__LD02_LogoFV_EN_V_____BW.jpg